RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Abiogen Pharma
A

Abiogen Pharma portfolio

Abiogen Pharma has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $125M.
Latest deal: Ambros Therapeutics · Dec 16, 2025.
About this page

Its most recent investment on record is Ambros Therapeutics's $125M Series A round in December 2025, alongside Transhuman Capital, Adage Capital Management, LifeSci Venture Partners and 5 others. That company is in Health and bio.

What Abiogen Pharma invests in

How Abiogen Pharma invests

StageDealsCapital in rounds
Series A 1 100%$125M

Abiogen Pharma portfolio companies

CompanyRound with Abiogen PharmaTotal raisedLatest raise
AAmbros Therapeutics
Health and bio
Series A · $125M$125MDec 16, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Abiogen Pharma. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Abiogen Pharma, which is a subset of its real portfolio. API: /api/v1/investors/abiogen-pharma (get a free API key). More: the most active VC firms and new venture capital funds.